Genetic Aspects of Cutaneous Malignant Melanoma

  • M. H. Greene
  • S. J. Bale
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 102)

Abstract

For those of us engaged in studying familial cancer in general, and familial melanoma in particular, it is both fitting and fascinating to learn that the first patient with malignant melanoma of the skin described in the English language literature was a member of a melanoma-prone family (Norris 1820). Writing in 1820, describing a patient he had treated 3 years earlier, Dr. William Norris (an eminent Scottish surgeon of the day) reported in graphic detail the now all-too-familiar downhill course of far-advanced, widely disseminated melanoma. At the end of his vivid clinical case report, Norris noted “It is remarkable that this gentleman’s father, about thirty years ago, died of a similar disease.... This tumor originated in a mole, and it will be worth mentioning that not only my patient and his children had many moles on various parts of their bodies, but also his own father and brothers had many of them.... These facts, together with a case that has come under my notice rather similar, would incline me to believe that this disease is hereditary.” Thus, Norris both described the first melanoma-prone kindred and raised the hypothesis that its melanoma susceptibility was related to the presence of numerous moles.

Keywords

Recombination Resi Bark Noma Dermatol 

Abbreviations

CMM

cutaneous malignant melanoma

DNS

dysplastic nevus syndrome

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ahuja MR, Schwab M, Anders F (1980) Linkage between a regulatory locus for melanoma cell differentiation and an esterase locus in Xiphophorus. J Heredity 71: 403–407Google Scholar
  2. Anders F (1982) The biology of an oncogene, based upon studies on neoplasia in Xiphophorus. In: Jaenicke L (ed) Biochemistry of differentiation and morphogenesis. Springer, Berlin Heidelberg New York, pp 91–115Google Scholar
  3. Anders F, Anders A (1978) Etiology of cancer as studied in the platyfishswordtail system. Biochem Biphys Acta 516: 61–95Google Scholar
  4. Anders F, Anders A, Klinke K (1973) Regulation of gene expression in the Gordon-Kosswig melanoma system. In: Schroder JH (ed) Genetics and mutagenesis of fish. Springer, Berlin Heidelberg New York, pp 33–52CrossRefGoogle Scholar
  5. Anderson DE (1971) Clinical characteristics of the genetic variety of cutaneous melanoma in man. Cancer 28: 721–725PubMedCrossRefGoogle Scholar
  6. Balaban G, Herlyn M, Guerry D, et al. (1984) Cytogenetics of human malignant melanoma and premalignant lesions. Cancer Genet Cytogenet 11: 429–439PubMedCrossRefGoogle Scholar
  7. Bale SJ, Chakravarti A, Greene MH (1985a) Cutaneous malignant melanoma and familial dysplastic nevi — evidence for autosomal dominance and pleiotropy. Am J Hum Genet (in press)Google Scholar
  8. Bale SJ, Greene MH, Mann D, Murray C, Goldin L, Johnson AH (1985b) Familial malignant melanoma is not linked to the HLA complex on chromosome 6. Int J Cancer 36: 439–443PubMedCrossRefGoogle Scholar
  9. Barger BO, Acton RT, Soong S-J, Roseman J, Balch C (1982) Increase in HLA-DR4 in melanoma patients from Alabama. Cancer Res 42: 4276–4279PubMedGoogle Scholar
  10. Berkelhammer J, Oxenhandler RW, Hook RR Jr, Hennessy JM (1982) Development of a new melanoma model in C57BL/6 mice. Cancer Res 42: 3157–3163PubMedGoogle Scholar
  11. Cawley EP (1952) Genetic aspects of malignant melanoma. AMA Arch Dermatol 65: 440–450CrossRefGoogle Scholar
  12. Chase GA, Foldstein MF, Breitner JC, Beatty TH, Self SG (1983) The use of life tables and survival analysis in testing genetic hypotheses, with an application to Alzheimer’s disease. Am J Epidemiol 117: 590–597PubMedGoogle Scholar
  13. Clark WH Jr, Min BH, Kligman LHL (1976) The developmental biology of induced malignant melanoma in guinea pigs and a comparison with other neoplastic system. Cancer Res 36: 4079–4091PubMedGoogle Scholar
  14. Clark WH Jr, Reimer RR, Greene MH, Ainsworth AM, Mastrangelo MJ (1978) Origin of familial melanoma from heritable melanocytic lesions: the B-K mole syndrome. Arch Dermatol 114: 732–738PubMedCrossRefGoogle Scholar
  15. Clark WH Jr, Elder DE, Guerry D, Epstein MN, Greene MH, Van Horn M (1984) A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 15: 1147–1165PubMedCrossRefGoogle Scholar
  16. Crutcher WA, Sagebiel RW (1984) Prevalence of dysplastic naevi in a community practice. Lancet 1: 729PubMedCrossRefGoogle Scholar
  17. Dean J, Greene MH, Reimer RR, LeSane FV, McKeen EA, Mulvihill JJ, Blattner WA, Herberman RB, Fraumeni JF Jr (1979) Immunologic abnormalities in melanoma-prone families JNCI 63: 1139–1145PubMedGoogle Scholar
  18. Duggleby WF, Stoll H, Priore HL, Greenwald P, Graham S (1981) A genetic analysis of melanomapolygenic inheritance as a threshold trait. Am J Epidemiol 114: 63–72PubMedGoogle Scholar
  19. Elder DE, Greene MH, Bondi EE, Clark WH Jr (1981) Acquired melanocytic nevi and melanoma–the dysplastic nevus syndrome. In: Ackerman AB (ed) Pathology of malignant melanoma. Masson, New York, pp 185–215Google Scholar
  20. Elder DE, Greene MH, Guerry D, Kraemer KH, Clark WH Jr (1982) The dysplastic nevus syndrome: our definition. Am J Dermatopathol 4: 445–460Google Scholar
  21. Fitzpatrick TB, Lerner AB, Calkins E, Summerson WH (1950) Malignant melanoma in horses. Proc Soc ExBiol Med 75: 394–410Google Scholar
  22. Gordon M (1927) The genetics of a viviparous top-minnow platypoecilus; the inheritance of two kinds of melanophores. Genetics 12: 253–283PubMedGoogle Scholar
  23. Greene MH (1984) The dysplastic nevus syndrome. Hosp Pract 19: 91–108Google Scholar
  24. Greene MH, Fraumeni JF Jr (1979) The hereditary variant of malignant malanoma. In: Clark WH Jr, Goldman LI, Mastrangelo MJ (eds) Human malignant melanoma. Grune and Stratton, pp 139–166Google Scholar
  25. Greene MH, Clark WH Jr, Tucker MA, Elder DE, Kraemer KH, Fraser MC, Bondi EE, Guerry D, Tuthill R, Hamilton R, LaRossa D (1980) Precursor nevi in cutaneous malignant melanoma - a proposed nomenclature. Lancet 2: 104Google Scholar
  26. Greene MH, Young TI, Clark WH Jr (1981) Malignant melanoma in renal transplant recipients. Lancet 1: 1196–1199PubMedCrossRefGoogle Scholar
  27. Greene MH, Goldin LR, Clark WH Jr, Lourien E, Kraemer KH, Tucker MA, Elder DE, Fraser MC, Rowe S (1983) Familial malignant melanoma: autosomal dominant trait possibly linked to the Rh locus. Proc Natl Acad Sci USA 80: 6071–6075PubMedCrossRefGoogle Scholar
  28. Greene MH, Clark WH Jr, Tucker MA, Elder DE, Kraemer KH, Guerry D, Witmer WK, Thompson J, Matozzo I, Fraser MC (1985) Acquired precursors of cutaneous malignant melanoma–the familial dysplastic nevus syndrome. N Engl J Med 312: 91–97PubMedCrossRefGoogle Scholar
  29. Greene MH, Clark WH Jr, Tucker MA, et al. (1985) The high risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann Intern Med 102: 458–464PubMedGoogle Scholar
  30. Haussier G (1928) Über Melanombildung bei Bastarden von Xiphophorous hellen and Platypoecilus maculatus var. rubra. Klin Wochenschr 7: 1561–1562CrossRefGoogle Scholar
  31. Hawkins BR, Dawkins RL, Hockey A, Houliston JB, Kirk RL (1981) Evidence for linkage between HLA and malignant melanoma. Tissue Antigens 17: 540–541PubMedCrossRefGoogle Scholar
  32. Hersey P, Edwards A, Honeyman M, McCarthy WH (1981) Low natural killer cell activity in familial melanoma patients and their relatives. Br J Cancer 40: 113–122CrossRefGoogle Scholar
  33. Holman CD, Armstrong BK (1984) Pigmentary traits, ethnic origin, benign nevi and family history as risk factors for cutaneous malignant melanoma. JNCI 72: 257–266PubMedGoogle Scholar
  34. Kosswig C (1927) Über Bastarde der teleostier Platypoecilus and Xiphophorus. Ztschrift für induktive Abstammungs and Vererbungslehre 44: 253CrossRefGoogle Scholar
  35. Kripke ML (1984) Immunological unresponsiveness induced by ultraviolet radiation. Immunol Rev 80: 87–102PubMedCrossRefGoogle Scholar
  36. Lynch HT, Fusaro RM, Kimberling WJ, Lynch JF, Shannon Danes B (1983) Familial atypical multiple mole-melanoma (FAMMM) syndrome-segregation analysis. J Med Genet 20: 342–344PubMedCrossRefGoogle Scholar
  37. Manning PJ, Milliken LE, Cox VS, Carey KD, Hook RR Jr (1974) Congenital cutaneous and visceral melanomas of Sinclair miniature swine: three case reports. JNCI 52: 1559–1566PubMedGoogle Scholar
  38. Morizot D, Siciliano M (1983) Linkage group V of platyfishes and swordtails of the genus Xiphophorus: linkage of loci for malate dehydrogenase-2, esterase-1 and esterase-4 with a gene controlling the severity of hybrid melanoma. JNCI 71: 809–813PubMedGoogle Scholar
  39. Norris W (1820) A case of fungoid disease. Edinb Med Surg J 16: 562–565Google Scholar
  40. Pellegris G, Illeni MT, Rovini D, Vaglini M, Cascinelli N, Ghidoni A (1982) HLA complex and familial malignant melanoma. Int J Cancer 29: 621–623PubMedCrossRefGoogle Scholar
  41. Reimer RR, Clark WH Jr, Greene MH, Ainsworth A, Fraumeni JF Jr (1978) Precursor lesions in familial melanoma. A new genetic preneoplastic syndrome. JAMA 239: 744–746PubMedCrossRefGoogle Scholar
  42. Rhodes AR, Sober AJ, Mihm MC Jr, Fitzpatrick TB (1980) Possible risk factors for primary cutaneous melanoma. Clin Res 28: 252AGoogle Scholar
  43. Rhodes AR, Harrist TJ, Day CL, Mihm MC Jr, Fitzpatrick TB, Sober AJ (1983) Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas. J Am Acad Dermatol 9: 563–574PubMedCrossRefGoogle Scholar
  44. St.-Areault G, Nagel G, Kirkpatrick D, Kirkpatrick R, Holland JF (1970) Cutaneous malignant melanoma in identical twins from a set of triplets. Cancer 25: 672–677CrossRefGoogle Scholar
  45. Sang JH (1969) Biochemical basis of hereditary melanotic tumors in Drosophila. NCIM 31: 291–301Google Scholar
  46. Scholl E (1980) Untersuchungen über biochemische Marker bei verschiedenen Genotypen lebend gebärender Zahnkarpten der Gutlung Xiphophorus. Doctoral dissertation, University of GiessenGoogle Scholar
  47. Siciliano MJ, Wright DA (1976) Biochemical genetics of the platyfishswordtail melanoma system. Prog Exp Tumor Res 20: 398PubMedGoogle Scholar
  48. Swerdlow Ai, English J, MacKie RM, O’Doherty CJ, Hunter JAA, Clark J (1984) Benign nevi associated with high risk of melanoma. Lancet 2: 168PubMedCrossRefGoogle Scholar
  49. Taylor MR, Guerry D, Bondi EE, Shields JA, Augsburger JJ, Lusk EJ, Elder DE, Clark WH Jr., Van Horn M (1984) Intraocular melanoma is not associated with a high prevalence of cutaneous dysplastic nevi. Am J Ophthalmol 98: 478–482PubMedCrossRefGoogle Scholar
  50. Tucker MA, Misfeldt D, Coleman CN, Clark WH Jr, Rosenberg SA, Kaplan HS (1985) Cutaneous malignant melanoma following Hodgkin’s disease. Ann Intern Med 102: 37–41PubMedGoogle Scholar
  51. Vandenbark A, Greene MH, Burger D, Vetto M, Reimer RR (1979) Immune response to melanoma extracts in three melanoma prone families. JNCI 63: 1147–1151PubMedGoogle Scholar
  52. Wallace DC, Exton LA, McLeod GRC (1971) Genetic factor in malignant melanoma. Cancer 27: 1262–1266PubMedCrossRefGoogle Scholar
  53. Wallace DC, Beardmore GL, Exton LA (1973) Familial malignant melanoma. Ann Surg 177: 15–20PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1986

Authors and Affiliations

  • M. H. Greene
    • 1
  • S. J. Bale
    • 1
  1. 1.National Cancer InstituteBethesdaUSA

Personalised recommendations